WORKING PAPERS
- Unlocking the Hidden Pharmaceutical Financing: Resilient R&D Investment and Malleable Selling Expenses, (with Tianyuan Jiang, Xuan Tian, and Xuan Zhang), Nov. 2025.
- Contracting on Price, Compensating on Quality: Evidence from Centralized Drug Procurement, (with Jiang Bin, Qingyuan Xue, Jiayu Zhang, and Xuan Zhang), March, 2026.
- Scaling Up Drug Procurement: Utilization Gains and Distributional Effects, (with Bin Jiang, Qingyuan Xue, Jiayu Zhang, and Xuan Zhang), March, 2026.
- SSNDQ Test for Multisided Platforms with Zero Prices, (with Jiong Gong, Yumin Li, and Yanhua Zhang), June 2024.
- 集采药企的省份供应决策及对药品可负担性的影响——基于新结构经济学视角的研究，（合作者：邓舒心，薛清元，刘凡瑜），2025年10月。
- Venture Capital and Knowledge Transfer, (with Roberta Dessi, Sanxi Li), June 2019.
WORK IN PROGRESS
- How Does NRDL Negotiation Promote the Use of High-Value Innovative Medicines? Evidence from Hospital Procurement Data, (with Bin Jiang, Chuhao Ji, Peixiong Lin, Fanyu Liu), Dec. 2025.
- The Impact of NRDL Negotiation on Innovation: Evidence from Listed Pharmaceutical Firms, (with Fanyu Liu, Qi Zhu), Dec. 2025.
- The Impact of the Double Reduction Policy on Children's Mental Disorders: Evidence from Hospital Procurement Data and CFPS, (with Heng Chen, Yongqi Li, Qingyuan Xue, Xuan Zhang), Dec. 2025.
PUBLICATIONS
- Has the Shortened Drug Distribution Chain Cut Drug Prices? Evidence from the Two-Invoice System in China (with Xiaoxi Li, Fanyu Liu and Jianye Yan), Journal of Health Economics, Volume 105, January 2026, 103097.
- Impact of Antitrust Events on Firm Market Value: Evidence from Chinese and U.S. Internet Platforms, (with Yong Huang, Yanhua Zhang and Shan Zhao), Review of Industrial Organization, 67, 251–288, 2025.
- Pharmaceuticals, Incremental Innovation and Market Exclusivity, International Journal of Industrial Organization, Volume 87, March 2023. ("The IJIO Best Empirical Paper 2023")
- New Clinical Information and Physician Prescribing: How Do Pediatric Labeling Changes Affect Prescribing to Children? (with Mary K. Olson), Health Economics, 30(1): 144-164, January 2021.
- Economic Analysis Under the Anti-Unfair Competition Law in China: Tencent v. Xinhui, (with Vanessa Yanhua Zhang and John Jiong Gong), CPI Antitrust Chronicle, March 2019.
- Multitask Assignments with Adverse Selection, (with Minbo Xu, Sanxi Li), Economics Letters, 181:127-132, August 2019.
- Examining Firm Responses to R&D Policy: An Analysis of Pediatric Exclusivity (with Mary K. Olson), American Journal of Health Economics 4(3): 321-357, Summer 2018.
- The Impact of Venture Capital on Innovation, (with Roberta Dessi), in D. Cumming, ed. The Oxford Handbook of Venture Capital, Oxford University Press, Chapter 22, 2012.
- Socio-economic Status and Chronic Diseases: The Case of Hypertension in China (with Xiaoyan Lei, Yaohui Zhao), China Economic Review, 23 (2012) 105-121.
- 双边市场中的排他性交易与补贴：平台竞争与社会福利分析, (合作者：李瑜敏，巩晓劼)，《世界经济文汇》，2024, 01(04): 1-24。
- 非正规金融的运行——社会网络的作用, (合作者：尹训东), 《世界经济文汇》, 2017, 1(01),51-68.
